Suspension - Beximco Pharmaceuticals PLC

RNS Number : 3288N

AIM

02 January 2026

NOTICE

02/01/2026 7:30am

TEMPORARY SUSPENSION OF TRADING ON AIM

BEXIMCO PHARMACEUTICALS PLC

Trading on AIM for the under-mentioned securities has been temporarily suspended from 02/01/2026 7:30am, pending publication of the Company's annual audited accounts.

GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH), FULLY PAID

(B0DM5S5) (US0885792061)

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 3368 3551 / 3555.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

EXCFDMFFFEISEEE

Date	2 Jan 2026
Time	07:30:01
Category	Corporate updates
ID	3288N

Date	2 Jan 2026
Time	07:30:01
Category	Corporate updates
ID	3288N

t

Company Information

AI Summary

RNS Metadata

Company Information

AI Summary

RNS Metadata

Suspension - Beximco Pharmaceuticals PLC